Both in Biotechnology
Maze Therapeutics vs Hemab Therapeutics Holdings
Over the past year MAZE returned +31.1% and COAG returned +9.4%; their daily moves had a correlation of 0.27.
MAZE +31.1% COAG +9.4%Growth of $1, one year, split-adjusted
| Metric | MAZE | COAG |
|---|---|---|
| Price | $32.25 | $43.10 |
| Market cap | $1.79B | $2.01B |
| Today | +6.19% | +4.66% |
| 1 month | +22.0% | +40.9% |
| 6 months | +21.4% | — |
| Year to date | −22.2% | — |
| 1 year | −2.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 89.6× | — |
| Net cash | $372.1M | $457.5M |
| Dividend yield | — | — |
| Volatility (60d) | 67.4% | — |
| Short % of float | 18.8% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).